vimarsana.com

Latest Breaking News On - Autologous cancer vaccine - Page 1 : vimarsana.com

Torigen Pharmaceuticals Opens New Headquarters and Promotes Two to Executive Leadership

Farmington, CT (PRWEB) April 25, 2023 Torigen Pharmaceuticals Inc., a commercial-stage animal health biologics company that recently completed its Series A

United statesUniversity of connecticutBryan clausonAshley kalinauskasTroy gobbettLeadership teamBusiness development managersTorigen team growthTorigen pharmaceuticals incUniversity of notre dameEmerald development managersPharmaceuticals incExecutive leadership teamVice presidentTeam growthEquine sales

Torigen Pharmaceuticals and Veterinary Management Groups Enter into Preferred Partner Agreement

Farmington, CT (PRWEB) April 13, 2023 Torigen Pharmaceuticals, Inc (Farmington, CT), an animal health biologics company, today announced it has entered

University of connecticutUnited statesMatthew saloisAshley kalinauskasTorigen pharmaceuticals inc farmingtonUniversity of notre dameEmerald development managersFounder of torigen pharmaceuticalsWerth family investment associatesTorigen pharmaceuticals incPreferred partner agreementVeterinary management groupsGeneral practitionersAutologous cancer vaccineVeterinary biologicsNotre dame

Torigen Pharmaceuticals and VerticalVet Enter into Preferred Partnership

Farmington, CT (PRWEB) December 08, 2022 Farmington, CT – DATE – Torigen Pharmaceuticals, Inc (Farmington, CT), an animal health biologics company,

University of connecticutUnited statesJohn wagonerHank swartzAshley kalinauskasWerth family investment associatesVeterinary servicesTorigen pharmaceuticals inc farmingtonTorigen pharmaceuticals incGroup purchasing organizationPartnership agreementEmerald development managersVimians groupUniversity of notre dameGroup resource communityFounder of torigen pharmaceuticals

Torigen Pharmaceuticals Inks National Distribution Deal with MWI Animal Health

Farmington, CT (PRWEB) June 22, 2022 Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, announced today that it has entered

University of connecticutUnited statesSean fitzgeraldAshley kalinauskasMarket developmentTorigen pharmaceuticals incUniversity of notre dameEmerald development partnersAnimal healthFounder of torigen pharmaceuticalsVeterinary biologicsVice presidentSteve shellAutologous cancer vaccineNotre dameWerth ventures

Torigen Expands Histopathology Services Through Strategic Partnership with Vidium Animal Health

Farmington, CT (PRWEB) April 27, 2022 Torigen Pharmaceuticals, Inc, a commercial-stage animal health biologics company, today announced it has entered into

University of connecticutUnited statesDerick whitleyAshley kalinauskasWerth family investment associatesVidium animal healthTranslational genomics research institute tgenTorigen pharmaceuticalsTorigen pharmaceuticals incUniversity of notre dameEmerald development partnersVidium animal health viceAnimal healthVidium animal health vice presidentAutologous cancer vaccineVeterinary biologics

vimarsana © 2020. All Rights Reserved.